Moderna doses first patient in study on its Covid-19 booster vaccine
Coronavirus: On 16 November, 2020, US biotech company Moderna announced a vaccine against Covid-19 that is 94.5% effective. Montreal, 16 November, 2020/ Reuters
Moderna Inc said on Monday it has dosed the first patient in an early-stage study of its Covid-19 vaccine candidate, being evaluated as a potential booster shot for previously vaccinated people.
